膀胱癌术后复发及进展相关分子标志物研究进展  

Progress in the Research of Molecular Markers about the Recurrence and Progress of Bladder Cancer after Surgery

作　　者：刘绍远[1] 张海滨[1] 杨明[1] 

机构地区：[1]中山大学附属佛山医院佛山市第一人民医院泌尿外科,广东佛山528000

出　　处：《医学综述》2011年第23期3572-3574,共3页Medical Recapitulate

摘　　要：目前比较肯定的与膀胱癌复发和进展相关的因素包括肿瘤分级及分期,但肿瘤的分级与分期并不能完全反映肿瘤的复发和进展倾向。如何早期预测膀胱癌术后复发和进展一直是泌尿外科临床研究的热点问题之一。膀胱癌生物学标记是在分子水平上寻找答案,并且候选标记众多,研究前景十分广阔。近年来,发现了一些可用来预测膀胱癌术后复发和进展相关的分子标志物,现就这些分子标志物予以综述。Currently,the relatively positive factors related to the recurrence and progress of bladder cancer include tumor grade and stage,but the grade and stage of tumor can not fully reflect the tendency of the recurrence and progress.That how to early predict the recurrence and progress of bladder cancer has been one of the hot topics in clinical research of urology.The biological marks of bladder cancer may be the answers in the molecular levels and there is lots of candidate markes.The research of the the biological marks have a bright future.In recent years,some molecular marks which can be used to predict the recurrence and progress of bladder cancer after surgery are found,and here is to review the molecular markers.

关 键 词：膀胱肿瘤 预后 分子标记物 

分 类 号：R737.14[医药卫生—肿瘤]